Prelude Therapeutics Incorporated (PRLD)

NASDAQ: PRLD · Real-Time Price · USD

3.230

+0.110 (3.53%)

At close: Mar 6, 2026, 4:00 PM EST

3.280

+0.050 (1.55%)

After-hours: Mar 6, 2026, 7:17 PM EST

Prelude Therapeutics Market Cap

Prelude Therapeutics has a market cap or net worth of $266.14 million as of March 6, 2026. Its market cap has increased by 288.70% in one year.

Market Cap

266.14M

Enterprise Value

229.04M

1-Year Change

288.70%

Ranking

#3614

Market Cap Chart

Since the IPO on September 25, 2020, Prelude Therapeutics's market cap has decreased from $806.64M to $266.14M, a decrease of -67.01%. That is a compound annual growth rate of -18.42%.

Market Cap History

Date	Market Cap	% Change
Mar 6, 2026	266.14M	11.38%
Dec 31, 2025	238.95M	147.03%
Dec 31, 2024	96.73M	-70.04%
Dec 29, 2023	322.85M	12.32%
Dec 30, 2022	287.43M	-50.22%
Dec 31, 2021	577.35M	-80.97%
Dec 31, 2020	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Sol-Gel Technologies	246.26M
Achieve Life Sciences	243.81M
Nuvectis Pharma	239.22M
Context Therapeutics	238.89M
Alector	237.28M
Voyager Therapeutics	229.63M
Protalix BioTherapeutics	227.59M
MediWound	225.55M

Market Cap Rankings